Learn Glossary Market Stocks Superinvestors Sign in

XOMAO

XOMA Corporation

Healthcare · $302M market cap

We can't put a fair value on XOMAO right now. It looks like a preferred share, note or other security rather than ordinary common stock. The figures we receive belong to the parent company, so they can't value this security.

Business quality

0 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?

Equity per share growth-18.2% a year✗

Sales growth-6.1% a year✗

Free cash flow growth-2.4% a year✗

Return on invested capital-9.4%✗

Follow XOMAO

Track it on your watchlist and see the full analysis. Free.

Create a free account

Insider activity

Since Jul 14, 2026: no open-market purchases and 66 other filings (stock awards, tax withholding and similar). Why purchases matter

Other filings

Franklin Heather L

director · 2026-07-14

D-Return

$241K

Franklin Heather L

director · 2026-07-14

D-Return

$235K

Franklin Heather L

director · 2026-07-14

D-Return

$161K

Franklin Heather L

director · 2026-07-14

D-Return

$542K

Franklin Heather L

director · 2026-07-14

J-Other

$47

Show all 66 other filings

Trigilio Jeffrey

Chief Financial Officer · 2026-07-14

D-Return

26,000 shares

Trigilio Jeffrey

Chief Financial Officer · 2026-07-14

J-Other

$779

PERRY MATTHEW D

director · 2026-07-14

D-Return

$235K

PERRY MATTHEW D

director · 2026-07-14

D-Return

$161K

PERRY MATTHEW D

director · 2026-07-14

D-Return

$158K

PERRY MATTHEW D

director · 2026-07-14

D-Return

$131K

PERRY MATTHEW D

director · 2026-07-14

D-Return

$127K

PERRY MATTHEW D

director · 2026-07-14

D-Return

$127K

PERRY MATTHEW D

director · 2026-07-14

D-Return

$71K

PERRY MATTHEW D

director · 2026-07-14

J-Other

$181

Sitko Bradley

Chief Investment Officer · 2026-07-14

D-Return

23,488 shares

Sitko Bradley

Chief Investment Officer · 2026-07-14

D-Return

$7.5M

Sitko Bradley

Chief Investment Officer · 2026-07-14

D-Return

$5.6M

Sitko Bradley

Chief Investment Officer · 2026-07-14

D-Return

$100

Sitko Bradley

Chief Investment Officer · 2026-07-14

D-Return

$4

Sitko Bradley

Chief Investment Officer · 2026-07-14

J-Other

$11

Hernday Natasha

director · 2026-07-14

D-Return

$121K

Hernday Natasha

director · 2026-07-14

D-Return

$235K

Hernday Natasha

director · 2026-07-14

D-Return

$161K

Hernday Natasha

director · 2026-07-14

D-Return

$158K

Hernday Natasha

director · 2026-07-14

D-Return

$262K

Hernday Natasha

director · 2026-07-14

D-Return

$200

Hernday Natasha

director · 2026-07-14

J-Other

$70

Hughes Owen

Chief Executive Officer · 2026-07-14

D-Return

132,714 shares

Hughes Owen

Chief Executive Officer · 2026-07-14

D-Return

$2.3M

Hughes Owen

Chief Executive Officer · 2026-07-14

D-Return

$1.9M

Hughes Owen

Chief Executive Officer · 2026-07-14

D-Return

$5K

Hughes Owen

Chief Executive Officer · 2026-07-14

J-Other

$6

WYSZOMIERSKI JACK L

director · 2026-07-14

D-Return

$235K

WYSZOMIERSKI JACK L

director · 2026-07-14

D-Return

$161K

WYSZOMIERSKI JACK L

director · 2026-07-14

D-Return

$158K

WYSZOMIERSKI JACK L

director · 2026-07-14

D-Return

$131K

WYSZOMIERSKI JACK L

director · 2026-07-14

D-Return

$127K

WYSZOMIERSKI JACK L

director · 2026-07-14

D-Return

$127K

WYSZOMIERSKI JACK L

director · 2026-07-14

D-Return

$46K

WYSZOMIERSKI JACK L

director · 2026-07-14

D-Return

$32K

WYSZOMIERSKI JACK L

director · 2026-07-14

J-Other

$164

Kosacz Barbara

director · 2026-07-14

D-Return

$241K

Kosacz Barbara

director · 2026-07-14

D-Return

$235K

Kosacz Barbara

director · 2026-07-14

D-Return

$161K

Kosacz Barbara

director · 2026-07-14

D-Return

$158K

Kosacz Barbara

director · 2026-07-14

D-Return

$131K

Kosacz Barbara

director · 2026-07-14

D-Return

$127K

Kosacz Barbara

director · 2026-07-14

D-Return

$253K

Kosacz Barbara

director · 2026-07-14

J-Other

$47

LIMBER JOSEPH M

director · 2026-07-14

D-Return

$250K

LIMBER JOSEPH M

director · 2026-07-14

D-Return

$241K

LIMBER JOSEPH M

director · 2026-07-14

D-Return

$235K

LIMBER JOSEPH M

director · 2026-07-14

D-Return

$161K

LIMBER JOSEPH M

director · 2026-07-14

D-Return

$158K

LIMBER JOSEPH M

director · 2026-07-14

D-Return

$131K

LIMBER JOSEPH M

director · 2026-07-14

D-Return

$127K

LIMBER JOSEPH M

director · 2026-07-14

D-Return

$127K

LIMBER JOSEPH M

director · 2026-07-14

D-Return

$46K

LIMBER JOSEPH M

director · 2026-07-14

D-Return

$32K

LIMBER JOSEPH M

director · 2026-07-14

D-Return

$1K

LIMBER JOSEPH M

director · 2026-07-14

D-Return

$500

LIMBER JOSEPH M

director · 2026-07-14

J-Other

$71

Montano Maricel Perea

Chief Legal Officer · 2026-07-14

D-Return

11,316 shares

Montano Maricel Perea

Chief Legal Officer · 2026-07-14

J-Other

$0

BVF PARTNERS L P/IL

Owns 10%+ · 2026-07-14

U-Tender

$30.1M

About XOMA Corporation

Based in Emeryville, California, and founded in 1981, XOMA Corporation functions as a specialized biotechnology royalty aggregator, with operations spanning Europe, the United States, and the Asia Pacific. The company's core mission is to contribute to advancing human health by empowering other biotechnology firms. XOMA achieves this by purchasing the future economic interests, often in the form of royalties…

Biotechnology

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Jul 14, 2026. How the Payback Price works